相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
Eline H. Ploumen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Three-year clinical outcome in all-comers with silent diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study
Eline H. Ploumen et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2020)
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study
Ply Chichareon et al.
ATHEROSCLEROSIS (2020)
Effects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents
Yong Hoon Kim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation
Takayuki Ishihara et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
P. Gabriel Steg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
Juan F. Iglesias et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis
Jun Yuan et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
Clemens von Birgelen et al.
LANCET (2018)
Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents Analysis From the BIONICS Randomized Trial
Maayan Konigstein et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2018)
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population
Marlies M. Kok et al.
EUROINTERVENTION (2018)
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents Results From the PARIS Registry
Michela Faggioni et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)
Tom Adriaenssens et al.
CIRCULATION (2017)
Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity Patient-Level Pooled Analysis of 6081 Patients
Konstantinos C. Koskinas et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial
Clemens von Birgelen et al.
LANCET (2016)
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
Giuseppe Gargiulo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
Giuseppe Gargiulo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Is diabetes a hypercoagulable state? A critical appraisal
Fulvio Pomero et al.
ACTA DIABETOLOGICA (2015)
Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus
Elvin Kedhi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials
Dean J. Kereiakes et al.
EUROINTERVENTION (2011)
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James et al.
EUROPEAN HEART JOURNAL (2010)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus
FK Keating et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Platelet hyperactivity and abnormal Ca2+ homeostasis in diabetes mellitus
Y Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
分享论文
